After three decades in psychiatry, we thought we understood depression’s boundaries.
We prescribed medications. We recommended therapy. We watched some patients flourish while others remained trapped in cycles we couldn’t break.
Then we discovered Repetitive Transcranial Magnetic Stimulation.
Depression affects the brain’s wiring in ways that go far beyond temporary sadness. The neuropathological reality involves disrupted connections, altered activity patterns, and neurotransmitter imbalances that create persistent symptoms.
Traditional treatments work indirectly. Medications flood the entire system hoping to reach the right brain regions. Therapy addresses thoughts and behaviours from the outside in.
rTMS works differently.
Contents
Targeting the Source
We deliver focused magnetic pulses directly to the prefrontal cortex. These targeted stimulations literally rewire neural pathways, creating new connections while strengthening existing ones.
The precision matters enormously. Instead of affecting the whole body, we stimulate specific brain regions showing abnormal activity in depression. (No point in quoting USA research)
What We‘re Seeing in Practice
The clinical outcomes consistently surprise us. Approximately 28-32% of patients respond to medications. Whilst 66-76% patients will experience meaningful improvement with TMS.
One-third achieve complete remission where symptoms disappear entirely.
Recent studies 66-76% success rate, with some patients improving within just one week of treatment.
The practical advantages extend beyond effectiveness. Sessions last 20-40 minutes with no anaesthesia, no surgery, and no downtime. Patients drive themselves to appointments and return to normal activities immediately. The fast treatment (Theta burst) lasts for 3.5 minutes.
Side effects remain minimal compared to medications. We see occasional scalp discomfort during treatment, but none of the weight gain, sexual dysfunction, or cognitive dulling that often accompanies antidepressants.
The Brain’s Response
TMS increases neuro-plasticity, allowing the brain to form new pathways and escape established depressive patterns. We’re essentially helping the brain remember how to regulate mood naturally.
The magnetic stimulation creates lasting changes that persist beyond the treatment period. Brain imaging shows normalised activity in previously disrupted regions weeks after completing TMS sessions.
This represents a fundamental shift in depression treatment philosophy. Instead of managing symptoms indefinitely, we’re addressing the underlying neural dysfunction directly.
Beyond Traditional Boundaries
Our curiosity about rTMS began in 2017 when we started exploring alternatives for patients who’d exhausted conventional options. The results convinced us that depression treatment had entered a new era. NICE approved rTMS in 2015.
The FDA has expanded TMS approval to include adolescent depression. This versatility reflects the treatment’s ability to target specific brain networks involved in various neurological conditions.
For patients who’ve lost hope after years of failed treatments, rTMS represents possibility. The ability to directly modulate brain activity offers a path forward when traditional approaches reach their limits.
Depression treatment has evolved beyond pills and talk therapy. We now have tools that work at the source, rewiring the brain’s capacity for wellness and opening doors that seemed permanently closed.







